RECENT FUNDING ROUNDS
| Company | Country | Profile | Funding round | Value | Date | |
|---|---|---|---|---|---|---|
|
Eden Health Inc | Primary care and insurance navigation company. | Acquisition | |||
|
May Health | Medical device company focused on endocrine disorder polycystic ovary syndrome. | Series B | USD 25,000,000 | ||
|
Ajax Therapeutics Inc | Blood cancer biotech. | Series C | USD 95,000,000 | ||
|
ArkeaBio Corp | Developer of a vaccine to reduce livestock methane emissions. | Series A | USD 26,500,000 | ||
|
Zephyr AI Inc | Precision medicine startup. | Series A | USD 111,000,000 | ||
|
Ambience Healthcare Inc | "AI operating system" for health care organisations. | Series B | USD 70,000,000 | ||
|
Via Scientific Inc | Developer of a multi-omics platform. | N/A | USD 5,000,000 | ||
|
Calliditas Therapeutics AB | Biopharma company focused on identifying, developing, and commercialising novel treatments in orphan indications with significant unmet medical needs. | Debt | EUR 92,000,000 | ||
|
Parse Biosciences | Provider of single-cell sequencing solutions. | Series C | USD 50,000,000 | ||
|
|
Parse Biosciences | Provider of single-cell sequencing solutions. | Debt | |||
|
Vivodyne Inc | Philadelphia-based biotech that tests its drug candidates on lab-grown human organs. | Seed | USD 38,000,000 | ||
|
Atom Limbs Inc | Innovator in prosthetic technology. | Crowdfunding - Equity | |||
|
Brightline Inc | Mental telehealth startup focused on young people. | Series C | USD 105,000,000 | ||
|
|
Atom Limbs Inc | Innovator in prosthetic technology. | Grant | |||
|
|
Atom Limbs Inc | Innovator in prosthetic technology. | Pre Seed | |||
|
Small Door Veterinary | Veterinary care company. | Series A | USD 20,000,000 | ||
|
|
Parse Biosciences | Provider of single-cell sequencing solutions. | N/A | USD 7,000,000 | ||
|
Maridose LLC | Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs. | Pre Seed | USD 150,000 | ||
|
Abalone Bio | Antibody drug discovery. | Seed | |||
|
Whisper.ai Inc | Developer of hearing aids. | Series B | USD 35,000,000 |